Medicine injection labeling device based on two-dimensional code recognition
By adding a drug traceability QR code to the drug bottle and using a protective film to prevent accidental scanning, the problem of drug barcodes not being accurate to the smallest unit has been solved, enabling automatic filling of drug information and usage records, which facilitates the management of anesthetic drugs.
Patent Information
- Application Number
- CN202423215227.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-25
- Publication Date
- 2026-03-17
- Estimated Expiration
- 2034-12-25
AI Technical Summary
The existing drug traceability codes are only on the outer packaging box and are not accurate to the smallest unit. Each drug requires a manual prescription, which is time-consuming and prone to reuse.
A drug traceability QR code is added to each medicine bottle. The label is attached to the bottle with adhesive paper, and the QR code is covered with a protective film. Scanning the code generates a medical order entry, preventing accidental scanning and recording usage information.
It enables automatic filling of drug information, reduces human intervention, lowers operating costs, prevents drug outflow, ensures that each drug is linked to a patient, records usage details, and facilitates traceability.
Smart Images

Figure CN224005598U_ABST
Abstract
Description
Technical Field
[0001] This utility model belongs to the field of medical technology, specifically a drug injection labeling device based on QR code recognition. Background Technology
[0002] In the modern medical system, narcotic and psychotropic drugs are a special and crucial class of therapeutic agents, widely used in surgical anesthesia, pain management, treatment of mental illnesses, and scientific research. To facilitate the use of narcotic and psychotropic drugs, labels are usually affixed to the bottles to display key information such as the generic name, brand name, specifications, batch number, expiration date, and manufacturer information.
[0003] However, existing drug barcode traceability codes are only on the outer packaging box and are not accurate to the smallest unit (each vial). This requires anesthesiologists to write prescriptions and other burdensome tasks, which is very time-consuming. Automated manual anesthesia cabinets rely on manually inputting batch numbers of narcotic drugs, which results in multiple batch numbers being incompatible and requiring manual intervention. Furthermore, it is not convenient to distinguish between drugs, and duplicate use is likely to occur during use. Utility Model Content
[0004] To address the aforementioned technical problems, this utility model provides a drug injection labeling device based on QR code recognition. This solves the problem in the prior art where drug traceability codes are only on the outer packaging box and are not accurate to the smallest unit (each vial). This requires anesthesiologists to write prescriptions, collect medications, and register them, which is very time-consuming.
[0005] A drug injection labeling device based on QR code recognition includes:
[0006] The label body has a drug traceability QR code installed on its surface, and an adhesive paper is installed at the rear end of the label body, with a vial connected to the rear end of the adhesive paper.
[0007] An adhesive strip is installed on the surface of the label body at the bottom of the drug traceability QR code. A protective film is connected to the top of the adhesive strip, and a pull paper is connected to the top of the protective film.
[0008] Preferably, an ampoule is connected to the rear end of the adhesive paper.
[0009] Preferably, tear strips are connected to both sides of the bottom of the protective film, and the tear strips extend into the interior of the label body.
[0010] Preferably, the label body surface on both sides of the tear strip is provided with opening guide lines.
[0011] Compared with the prior art, the present invention has the following beneficial effects:
[0012] 1. This utility model automatically fills in information such as drug name, specifications, usage information, manufacturer, date, and batch number by scanning the drug traceability QR code on the drug bottle. This ensures that each drug is linked to the patient at the time of use, preventing issues such as inconsistent batch numbers or randomly filled batch numbers. Scanning the code generates medical orders and electronic prescriptions for controlled substances with one click. The operation is simple and cost-effective, reducing the burden of typing medical orders and prescriptions, minimizing human intervention in the batch numbers of controlled substances, and preventing the outflow of controlled substances. At the same time, scanning the drug traceability QR code can also record and obtain information such as the scanning time and number of scans, facilitating subsequent traceability of controlled substances.
[0013] 2. This utility model uses a protective film installed on the label. By pulling the paper, the protective film is torn downwards and peeled off from the surface of the drug traceability QR code. At the same time, the adhesive strip is used to tear the surface of the label body, causing damage to the label body surface, so as to facilitate differentiation. The protective film covers and protects the drug traceability QR code to avoid accidental scanning. Attached Figure Description
[0014] Figure 1 This is a perspective view of the present utility model;
[0015] Figure 2 This is a schematic diagram of the structure of the label body and the ampoule bottle of this utility model;
[0016] Figure 3 This is a schematic diagram of the structure of the label body and the protective film of this utility model;
[0017] Figure 4 This is a schematic diagram of the structure of the label body and the opening guide line of this utility model;
[0018] Figure 5 This is a cross-sectional view of the label body and protective film of this utility model.
[0019] In the picture:
[0020] 1. Label body; 2. Adhesive paper; 3. Drug traceability QR code; 4. Vial; 5. Ampoule; 6. Protective film; 7. Pull paper; 8. Adhesive strip; 9. Opening guide line; 10. Tear strip. Detailed Implementation
[0021] The embodiments of this utility model will be described in further detail below with reference to the accompanying drawings and examples. The following examples are for illustrative purposes only and should not be construed as limiting the scope of this utility model.
[0022] As attached Figure 1 Appendix Figure 2 Appendix Figure 3 Appendix Figure 4 and attached Figure 5 As shown:
[0023] Example 1: This utility model provides a drug injection labeling device based on QR code recognition, comprising:
[0024] The label body 1 has a drug traceability QR code 3 installed on its surface, and an adhesive paper 2 is installed at the rear end of the label body 1. The rear end of the adhesive paper 2 is connected to a vial 4.
[0025] Adhesive strip 8 is installed on the surface of the label body 1 at the bottom of the drug traceability QR code 3. A protective film 6 is connected to the top of the adhesive strip 8, and a pull paper 7 is connected to the top of the protective film 6.
[0026] Among them, the drug traceability QR code 3 integrates and records the name, batch number, specifications, and manufacturer information of each psychotropic drug, and connects to the hospital system. By scanning the drug traceability QR code 3, the traceability of psychotropic drugs can be achieved.
[0027] As can be seen from the above, a drug traceability QR code 3 is added to the label body 1 of each bottle of narcotic and psychotropic drugs. After the label body 1 is attached to the vial 4 with adhesive paper 2, the adhesive strip 8 is attached to the surface of the label body 1 below the drug traceability QR code 3. The drug traceability QR code 3 is shielded and protected by a protective film 6 to avoid accidental scanning. When scanning is required, the protective film 6 is torn downwards with the pull paper 7. At the same time as the protective film 6 is peeled off from the surface of the drug traceability QR code 3, the adhesive strip 8 is used to tear the surface of the label body 1, causing damage to the surface of the label body 1 for easy identification.
[0028] Anesthesiologists can scan the drug traceability QR code on the drug bottle to automatically fill in information such as drug name, specifications, usage information, manufacturer, date, and batch number. This ensures that each drug is linked to the patient at the time of use, preventing issues such as inconsistent batch numbers or randomly filled batch numbers. Scanning the code generates medical orders and electronic prescriptions for controlled substances with a single click. The operation is simple and cost-effective, reducing the burden of typing medical orders and prescriptions, minimizing human intervention in the batch numbers of controlled substances, and preventing the outflow of controlled substances. At the same time, scanning the drug traceability QR code can also record and obtain information such as the scanning time and number of scans, facilitating subsequent traceability of controlled substances.
[0029] As attached Figure 2 As shown:
[0030] Specifically, regarding the aforementioned adhesive paper 2, the rear end of the adhesive paper 2 is connected to an ampoule 5.
[0031] The dimensions of the label body 1 and the adhesive paper 2 are made according to the diameter of the ampoule 5.
[0032] As can be seen from the above, after the label body 1 is pasted on the outside of the ampoule 5 by the adhesive paper 2, the medicine inside the ampoule 5 can be labeled so that medical staff can use the medicine.
[0033] As attached Figure 4 and attached Figure 5 As shown:
[0034] Example 2: This example is basically the same as the previous example, except that:
[0035] Tear strips 10 are attached to both sides of the bottom of the protective film 6, and the tear strips 10 extend into the interior of the label body 1.
[0036] The label body 1 on both sides of the tear strip 10 has an opening guide line 9.
[0037] As can be seen from the above, when the protective film 6 is peeled off downwards by the pull paper 7, the tear strip 10 is also pulled off downwards, which expands the area of damage caused by the adhesive strip 8 to the surface of the label body 1. The opening guide line 9 can reduce the overall strength of the label body 1, reduce the resistance encountered by the tear strip 10 when it is peeled off, and save manpower.
[0038] In this utility model, unless otherwise explicitly specified and limited, the terms "installation," "connection," "joining," and "fixing," etc., should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral part; they can refer to a mechanical connection or an electrical connection; they can refer to a direct connection or an indirect connection through an intermediate medium; they can refer to the internal communication of two components or the interaction between two components. Those skilled in the art can understand the specific meaning of the above terms in this utility model according to the specific circumstances.
[0039] In this utility model, unless otherwise explicitly specified and limited, "above" or "below" the second feature can mean that the first feature is in direct contact with the second feature, or that the first feature is in indirect contact with the second feature through an intermediate medium. Furthermore, "above," "on top of," and "over" the second feature can mean that the first feature is directly above or diagonally above the second feature, or simply that the first feature is at a higher horizontal level than the second feature. "Below," "below," and "under" the second feature can mean that the first feature is directly below or diagonally below the second feature, or simply that the first feature is at a lower horizontal level than the second feature.
[0040] The embodiments of this utility model are given for the purpose of illustration and description. Although embodiments of this utility model have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the utility model. Those skilled in the art can make changes, modifications, substitutions and variations to the above embodiments within the scope of this utility model.
Claims
1. A medicine injection tag device based on two-dimensional code recognition, characterized in that, Include: The surface of the label body (1) is provided with a drug traceability two-dimensional code (3), the rear end of the label body (1) is provided with an adhesive paper (2), and the rear end of the adhesive paper (2) is connected with a vial (4); The paste strip (8) is installed on the surface of the label body (1) at the bottom of the drug traceability two-dimensional code (3), the top of the paste strip (8) is connected with a protective film (6), and the top of the protective film (6) is connected with a paper puller (7); The bottom of the protective film (6) is connected with a tear strip (10) on both sides, and the tear strip (10) extends to the inside of the label body (1); The surface of the label body (1) on both sides of the tear strip (10) is provided with an opening guide line (9).
2. The medicine injection label device based on two-dimensional code recognition according to claim 1, characterized in that: The rear end of the adhesive paper (2) is connected with an ampoule (5).